CN110944619A - Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane as emulsifier containing fragrance material - Google Patents
Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane as emulsifier containing fragrance material Download PDFInfo
- Publication number
- CN110944619A CN110944619A CN201880047512.XA CN201880047512A CN110944619A CN 110944619 A CN110944619 A CN 110944619A CN 201880047512 A CN201880047512 A CN 201880047512A CN 110944619 A CN110944619 A CN 110944619A
- Authority
- CN
- China
- Prior art keywords
- weight
- group
- oil
- branched
- polydimethylsiloxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
A cosmetic or dermatological water-in-oil emulsion comprising: A) cetyl diglyceryl tris (trimethylsilyl)Alkoxy) silylethyl polydimethylsiloxane as an emulsifier; B) an oil phase; C) an aqueous phase characterized by containing benzoic acid and/or one or more substances of formula (I) and/or formula (II) having the general structure: wherein X may represent a branched or unbranched C1‑C4An alkyl chain, a hydroxyl group or an O group, and if X represents an O group, the dotted bond represents a double bond, and R may represent, independently of X, a branched or unbranched C1‑C4Alkyl chain, oxygen-bridged branched or unbranched C1‑C4An alkyl chain or a hydroxyl group;
Description
Technical Field
The invention relates to cosmetic preparations in the form of water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane as emulsifier, which contain low molecular weight fragrance substances.
Background
Users have placed a range of demands on modern skin care products, particularly in the form of a facial cream for use on the face. They should care for the skin, especially to provide moisture to the skin over an extended period of time. This is usually achieved by "moisturizers" which bind water in the stratum corneum (e.g. glycerol) and furthermore keep the squamous epithelium soft with added lipids and reduce transepidermal water loss.
Furthermore, the user often expects effects against the signs of skin aging, such as the formation of wrinkles, a decrease in skin elasticity, or the development of age spots. For this purpose, for example, active substances which stimulate the activity of skin cells are used on the one hand, but more and more UV filters are also used which block UVA radiation which is responsible in particular for skin ageing. All these ingredients constitute a great sensory challenge, since they remain on the skin as a film after evaporation of the volatile components of the formulation, where they are perceived by the consumer in the sense of the sense. In this case, the perceptible residue is often described as negative, which makes it impossible to feel the complete "absorption" of the product into the skin.
Consumers prefer to use conventional W/O emulsions for treating or treating dry skin. W/O emulsions have advantages even when incorporating color pigments, such as in colored day creams and color cosmetics. Unfortunately, many W/O emulsions have such negative characteristics: they leave an oily residue on the skin which is only slowly absorbed. In addition, their physical stability is often limited. This is particularly problematic when the W/O emulsion is to be formulated with fragrance materials.
Silicone-based emulsifiers have, almost without exception, PEG-and PPG-containing groups as hydrophilic components. Typical representatives are cetyl PEG/PPG-10/1 dimethicone (Abil EM 90, 180) from Evonik corporation or PEG-10 dimethicone (ES-5612 formulation aid) from Dow Corning corporation. These examples are successful and mature W/O emulsifiers on the market. However, the choice of silicone emulsifiers without PEG is limited. For example, there are KF-6100, KF-6104, KF-6105 or KSG-710, KSG-810, KSG-820, KSG-830 or KSG-840 from Shin Etsu or Abil EM 120 from Evonik.
Typically, these W/O silicone emulsifiers are used in high concentrations of a few percent. The choice of oil for W/O emulsions and in particular for W/Si emulsions is limited, since a high proportion of non-polar oil is required for good long-term stability. Therefore, in the W/Si emulsion, silicone oil and/or liquid hydrocarbon are substantially used.
Disclosure of Invention
It was therefore an object of the present invention to provide a stable (storage-stable, transport-stable, long-term stable) water-in-oil (W/O) emulsion which can be organoleptically attractive, which is PEG-free and in which fragrances can be incorporated, but in this case meets all the requirements for modern facial care products.
Overall, the main problem remains that water-in-oil emulsions tend to be unstable. Known disadvantages of this type are oil precipitation and phase separation. The problem becomes greater when fragrance materials have to be added. Although this can be counteracted by using known stabilizers, such as hectorite, or the proportion of the oil phase can be reduced. However, other disadvantages must therefore be borne, such as the poor incorporation of polar lipophilic substances, for example UV filters.
It is therefore an object of the present invention to overcome these disadvantages.
A particularly interesting emulsifier is cetyl diglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane by the company Dow Corning under the INCI name and sold under the trade name ES-5600.
Low molecular weight fragrance materials are common components in cosmetic formulations. Their structure and function may vary widely. The low molecular weight aromatic materials may be from the terpenes, used as part of a perfume oil. Other low molecular weight aromatic materials may also have antimicrobial or antioxidant properties. Many of these materials are good solvents, which have a negative effect on the stability of the W/O emulsion. An example of this is benzyl alcohol. It is therefore surprising and unforeseeable for the person skilled in the art that other similar fragrant substances do not have such a strong destabilizing effect on W/O emulsions comprising cetyldiglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane as emulsifier.
It is therefore surprising and unforeseeable for the person skilled in the art that the object on which the invention is based is achieved by a cosmetic or dermatological water-in-oil emulsion comprising:
A) cetyl diglyceryl tri (trimethylsiloxy) silyl ethyl polydimethylsiloxane as emulsifier
B) Oil phase
C) The water phase of the mixture is water phase,
characterized in that it comprises benzoic acid and/or one or more substances of formula (I) and/or formula (II) having the general structure:
wherein X may beDenotes branched or unbranched C1-C4An alkyl chain, a hydroxyl group or an O group, and if X represents an O group, the dotted bond represents a double bond, and R may represent, independently of X, a branched or unbranched C1-C4Alkyl chain, oxygen-bridged branched or unbranched C1-C4Alkyl chains or hydroxy groups
Advantageously according to the invention, the water-in-oil emulsion comprises from 0.1 to 10.0% by weight, preferably from 0.2 to 5.0% by weight, particularly preferably from 0.5 to 4.0% by weight, of cetyldiglyceryltri (trimethylsiloxy) silylethyl polydimethylsiloxane, relative to the total weight of the formulation.
Preferably, the compound(s) of formula (I) and/or (II) is selected from the group of methylparaben, ethylparaben, Cymenol (Cymenol), hydroxyacetophenone.
The CAS number for cymene alcohol or o-cymene-5-ol (IUPAC name 3-methyl-4- (1-methylethyl) phenol) is 3228-02-02, having the following structure:
ethylparaben (ethylparaben) has a CAS number of 120-47-8 and has the following structure:
methylparaben (methylparaben) has a CAS number of 99-76-3 and has the following structure:
4-hydroxyacetophenone (also known as coniferol) has a CAS number of 99-93-4 and the following structure:
advantageously according to the invention, the water-in-oil emulsion comprises 0.001 to 5.0% by weight, preferably 0.01 to 3.0% by weight, particularly preferably 0.1 to 1.0% by weight, relative to the total weight of the formulation, of benzoic acid and/or one or more compounds of formula (I) and/or (II), in particular one or more compounds selected from the group of methylparaben, ethylparaben, cymenol, hydroxyacetophenone.
It could not be expected that the formulations according to the invention would be comparable to the formulations of the prior art
-functions better than a moisturizing preparation,
-the ease of formulation is increased,
-better promotion of skin smoothness,
characterized by a better care effect,
better as a vehicle for cosmetic and dermatological active substances,
better organoleptic properties, such as dispersion on the skin or penetration into the skin,
a vehicle more suitable for use as an organic UV filter,
higher stability to decomposition in the oil and water phases, and
highlighted by a better biocompatibility,
allows the production of stable, in particular thin liquid, formulations.
The preparations according to the invention are flowable, but can also be formulated as creams, have very good cosmetic properties, in particular with regard to viscosity, and have very good skin compatibility and skin care properties.
It is possible and advantageous according to the invention for the proportion of the oil phase of the formulation according to the invention to be freely selected in the range from 3 to 60% by weight, based on the total weight of the formulation.
In this case, the oil or lipid phase according to the invention may comprise all oils, fats, waxes and/or lipids which are customary in cosmetic preparations.
The aqueous phase of the preparations according to the invention may advantageously contain customary cosmetic auxiliaries, such as alcohols, in particular lower alcohols, preferably ethanol and/or isopropanol, or lower polyols and their ethers, preferably propylene glycol, glycerol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl ether, butylene glycol monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products, foam stabilizers, electrolytes, tanning agents, etc.
As essential components of the formulation according to the invention, it is possible to use:
-water or an aqueous solution,
-an aqueous ethanol solution,
-natural oils and/or chemically modified natural oils and/or synthetic oils;
fats, waxes and other natural and synthetic fatty bodies, preferably esters of fatty acids with lower-carbon-number alcohols, for example with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with lower-carbon-number alkanoic acids or with fatty acids;
-alcohols, diols or polyols of low carbon number and their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether and similar products.
In particular, mixtures of the above solvents are used.
According to the invention, the oil phase of the emulsions in the sense of the present invention optionally consists partly of silicone oil.
Preferably, the oil phase of the formulation according to the invention is selected from cyclic and/or linear silicones, also referred to as "silicone oils" in the context of the present disclosure. Such silicones or silicone oils may be present as monomers, which are generally characterized by structural elements, for example as follows
As linear silicones having a plurality of siloxy units, which are advantageously used according to the invention, they are generally characterized by the following structural elements:
wherein the silicon atoms may be substituted by the same or different alkyl and/or aryl residues, which are generally indicated herein by the residues R1-R4 (it is noted that the number of different residues is not necessarily limited to 4). In this case, m may take a value of 2 to 200,000.
Polydimethylsiloxane is advantageously chosen as the silicone oil. Other silicone oils, such as cyclomethicone (octamethylcyclotetrasiloxane), phenyl dimethicone, such as hexamethylcyclotrisiloxane, dimethicone, poly (methylphenylsiloxane), cetyl dimethicone, behenoxy dimethicone, are also advantageously used within the scope of the present invention.
However, it is possible to select the oil components from the group of other oil components without suffering major disadvantages.
It is preferred at this point to select the oil component of the oil phase of the formulation according to the invention entirely or to a large extent entirely from the group of oils of synthetic and/or natural origin. They can then advantageously be selected from the group of esters of saturated and/or unsaturated, branched and/or unbranched alkanoic acids having a chain length of from 3 to 30 carbon atoms with saturated and/or unsaturated, branched and/or unbranched alcohols having a chain length of from 3 to 30 carbon atoms, and of aromatic carboxylic acids with saturated and/or unsaturated, branched and/or unbranched alcohols having a chain length of from 3 to 30 carbon atoms. Such ester oils may then advantageously be selected from the following group: isopropyl myristate, isopropyl palmitate, isopropyl stearate, n-decyl oleate, isooctyl stearate, isononyl isononanoate, cetearyl isononanoate, isodecyl neopentanoate, 2-ethylhexyl palmitate, 2-ethylhexyl laurate, 2-hexyldecyl stearate, cocoyl-caprylate/caprate, oleyl oleate, oleyl erucate, erucyl oleate, erucyl erucate, and synthetic, semi-synthetic and natural mixtures of these esters, such as jojoba oil.
Furthermore, the oily phase may advantageously be chosen in part from the group of branched and unbranched hydrocarbons and waxes, dialkyl ethers, the group of saturated or unsaturated, branched or unbranched alcohols, and also fatty acid triglycerides, in particular triglycerides of saturated and/or unsaturated, branched and/or unbranched alkanoic acids having a chain length of 8 to 24, in particular 12 to 18, carbon atoms. The fatty acid triglycerides may for example advantageously be selected from the group: synthetic, semi-synthetic and natural oils, such as caprylic capric triglyceride, coco glycerides, sunflower oil, soybean oil, almond oil and the like.
Also advantageous are mixtures of polydimethylsiloxane and cetearyl isononanoate.
Among the hydrocarbons, paraffin oil, squalane, hydrogenated polyisobutene, isohexadecane, isododecane; c15-19Alkane or polydecene.
The formulations according to the invention may also comprise one or more additional non-silicone emulsifiers, for example advantageously selected from the group of the following substances commonly used as W/O emulsifiers.
Sorbitan stearate, sorbitan oleate, glyceryl isostearate, polyglycerol-3 oleate, lanolin fatty acid mixtures, polyglycerol-3 diisostearate, methyl glucose dioleate, polyglycerol-4 isostearate, cetyl dimethicone copolyol, sorbitan isostearate, polyglycerol-2 dipolyhydroxystearate, polyglycerol-3 diisostearate, polyglycerol-4 dipolyhydroxystearate, PEG-30 dipolyhydroxystearate, diisostearoylpolyglycerol-3 diisostearate, polyglycerol-2 dipolyhydroxystearate, polyglycerol-3 dipolyhydroxystearate, polyglycerol-4 dipolyhydroxystearate.
The emulsions according to the invention in the sense of the present invention are advantageous, for example in the form of skin protection creams, skin lotions, cosmetic milks, for example in the form of sun creams or sun milks, and comprise, for example, fats, oils, waxes and/or other fatty bodies, as well as water and one or more emulsifiers customarily used in such formulations.
It is of course known to the person skilled in the art that it is generally not conceivable for highly demanding cosmetic compositions to be free of customary auxiliaries and additives. These include, for example, consistency agents, fillers, fragrances, dyes, emulsifiers, pigments, other active substances, such as vitamins or proteins, light protection agents, stabilizers, insect repellents, alcohols, water, salts, antimicrobial, proteolytic or keratolytic active substances, etc.
The corresponding requirements for the formulation of medical preparations apply, mutatis mutandis.
A medical topical composition in the sense of the present invention generally comprises one or more drugs in an effective concentration. For the sake of simplicity, legal provisions of the federal republic of germany (e.g. "cosmetic regulations" (kosmetikverrdnung) "," food and drug act "(Lebensmittel-undarzneimitelgesetz)") are cited for the clear distinction between cosmetic and pharmaceutical uses and the corresponding products.
Thus, according to their structure, the cosmetic or topical dermatological compositions in the sense of the present invention are used, for example, as skin protection creams, cleansing milks, sunscreen lotions, nourishing creams, day creams or night creams, etc. It is optionally possible and advantageous to use the composition according to the invention as a basis for a pharmaceutical formulation.
Also advantageous are such cosmetic and dermatological preparations in the form of sunscreen preparations. In addition to the active substances used according to the invention, at least one UVA filter substance and/or at least one UVB filter substance and/or at least one inorganic pigment is preferably additionally contained.
However, it is also advantageous in the sense of the present invention to prepare cosmetic and dermatological preparations whose main purpose is not to protect against sunlight, but which nevertheless contain a certain amount of UV-protective substances. For example, UV-A or UV-B filter substances are often incorporated in day creams.
Advantageously, the formulations according to the invention may comprise substances which absorb UV radiation in the UVB range, the total amount of filter substances being, for example, from 0.1 to 30% by weight, preferably from 0.5 to 10% by weight, in particular from 1 to 6% by weight, based on the total weight of the formulation.
The UVB filter may be oil-soluble or water-soluble. Examples of the oil-soluble substance include:
esters of cinnamic acid, preferably 4-methoxy cinnamic acid (2-ethylhexyl) ester
Esters of salicylic acid, preferably 2-ethylhexyl salicylate (salicylate), 4-isopropylbenzyl salicylate (salicylate),
-derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4 '-methylbenzophenone, 2' -dihydroxy-4-methoxybenzophenone;
-2,4, 6-trianilino- (p-carbonyl-2 '-ethyl-1' -hexyloxy) -1,3, 5-triazine.
As water-soluble substances are advantageous:
2-phenylbenzimidazole-5-sulfonic acid and salts thereof, for example sodium, potassium or triethanolammonium salts,
-sulfonic acid derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
sulfonic acid derivatives of 3-benzylidenecamphor, for example 4- (2-oxo-3-bornylidenemethyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bornylidenemethyl) sulfonic acid and salts thereof.
Of course, the list of UVB filters that can be used according to the invention should not be limiting.
It may also be advantageous to add UVA filters to the formulations according to the invention, which are usually contained in cosmetic and/or dermatological preparations. Such filter substances are preferably derivatives of dibenzoylmethane, in particular 1- (4' -tert-butylphenyl) -3- (4' -methoxyphenyl) propane-1, 3-dione and 1-phenyl-3- (4' -isopropylphenyl) propane-1, 3-dione. Formulations containing these combinations are also subject of the present invention. The same amount of UVA filter substance as described for the UVB filter substance may be used.
Cosmetic and/or dermatological preparations in the sense of the present invention may also contain inorganic pigments which are customarily used in cosmetics to protect the skin from the effects of ultraviolet light. They are oxides of titanium, zinc, iron, zirconium, silicon, manganese, aluminum, chromium, cerium and mixtures thereof, and variations in which the oxide is the active agent. But also ultramarine blue and pearlescent pigments. Pigments based on titanium dioxide are particularly preferred. The amounts mentioned for the above combinations may be used.
The cosmetic and dermatological preparations according to the invention may comprise cosmetically effective substances, auxiliaries and/or additives, such as are conventionally used in such preparations, for example antioxidants, preservatives, bactericides, fragrances, substances preventing foaming, dyes, pigments having a coloring effect, thickeners, surface-active substances, emulsifiers, softening substances, moisturizing substances and/or hydrating substances, fats, oils, waxes or other conventional constituents of cosmetic or dermatological formulations, such as alcohols, polyols, polymers, foam stabilizers, organic solvents or silicone derivatives.
Detailed Description
The following examples are intended to illustrate the invention without limiting it. All dosage data, ratios and percentages are based on the weight and total amount or total weight of the formulation, unless otherwise indicated.
To prepare the emulsions according to the invention, both a W/Si emulsifier and a W/O emulsifier are added to the oil phase. The ingredients of the oil phase are mixed together with a magnetic stirrer until homogeneous, with optional slight heating.
Sodium chloride and the corresponding aroma are dissolved in the aqueous phase. When ethylparaben is used, the aqueous phase is heated slightly as necessary to dissolve the starting material. The aqueous phase is then slowly added to the oil phase with stirring, followed by intensive mixing with a high speed mixer (e.g. magic rod ESGE) for about 2 minutes.
To determine the storage stability, all emulsion samples were stored in a screwed 30ml glass cup at different temperatures: room Temperature (RT) (about 20 ℃), -10 ℃, +40 ℃ and +50 ℃ and alternating temperatures of-10/+ 40 ℃.
Stability was assessed visually after 7 days, 14 days, 21 days (T) and 1 month (M).
By "stable" is meant that no or only little phase separation occurs, and no or only little oil precipitation occurs. By "slightly unstable" is meant that a moderate degree of visible phase separation or visibly apparent oil separation occurs. "unstable" refers to rapid, complete phase separation.
These experiments show that W/O emulsions with ES-5600 from Dow Corning have been stabilized by aromatic substances such as ethylparaben and hydroxyacetophenone, or at least the long term stability is extended. This is all the more surprising since the W/Si emulsion with benzyl alcohol is not stable.
The following examples are intended to explain the invention in more detail. Unless otherwise stated, data are in weight percent.
| Examples formulation/weight% | 1 | 2 | 3 | 4 |
| Benzyl alcohol | 0.2 | |||
| Hydroxyphenyl Ethyl ester | 0.2 | |||
| Hydroxyacetophenones | 0.2 | |||
| ES-5600 | 1 | 1 | 1 | 1 |
| Cetearyl isononanoate | 15 | 15 | 15 | 15 |
| Polydimethylsiloxane | 5 | 5 | 5 | 5 |
| Glycerol | 5 | 5 | 5 | 5 |
| Sodium chloride | 1 | 1 | 1 | 1 |
| Water (W) | To 100 of | To 100 of | To 100 of | To 100 of |
| Examples formulation 5 | By weight% |
| Cymene alcohol | 0.2 |
| ES-5600 | 1 |
| Cetearyl isononanoate | 15 |
| Polydimethylsiloxane | 5 |
| Glycerol | 5 |
| Sodium chloride | 1 |
| Water (W) | To 100 of |
| Examples formulation 6 | By weight% |
| Benzoic acid | 0.1 |
| ES-5600 | 1 |
| Cetearyl isononanoate | 10 |
| Cyclopolydimethylsiloxane | 10 |
| Glycerol | 5 |
| Sodium chloride | 1 |
| Water (W) | To 100 of |
Claims (5)
1. A cosmetic or dermatological water-in-oil emulsion comprising:
A) cetyl diglyceryl tri (trimethylsiloxy) silyl ethyl polydimethylsiloxane as an emulsifier,
B) an oil phase,
C) the water phase of the mixture is water phase,
characterized in that it comprises benzoic acid and/or one or more substances of formula (I) and/or formula (II) having the general structure:
wherein X represents a branched or unbranched C1-C4An alkyl chain, a hydroxyl group or an O group, and if X represents an O group, the dotted bond represents a double bond, and R represents, independently of X, a branched or unbranched C1-C4Alkyl chain, oxygen-bridged branched or unbranched C1-C4An alkyl chain or a hydroxyl group, and the like,
and benzoic acid.
2. An emulsion according to claim 1, characterized in that the compound(s) of formula (I) and/or (II) are selected from the group of methylparaben, ethylparaben, cymenol, hydroxyacetophenone.
3. Emulsion according to claim 1 or 2, characterized in that it comprises from 0.1 to 10.0% by weight, preferably from 0.2 to 5.0% by weight, particularly preferably from 0.5 to 4.0% by weight, of cetyldiglycidyltri (trimethylsiloxy) silylethyl polydimethylsiloxane, relative to the total weight of the formulation.
4. Emulsion according to any one of the preceding claims, characterized in that it comprises from 0.001 to 5.0% by weight, preferably from 0.01 to 3.0% by weight, particularly preferably from 0.1 to 1.0% by weight, relative to the total weight of the formulation, of one or more compounds of formula (I) and/or (II), in particular one or more compounds selected from the group of methylparaben, ethylparaben, cymene alcohol, hydroxyacetophenone and/or benzoic acid.
5. An emulsion according to any of the preceding claims, characterized in that the oil of the oil phase is preferably selected from the group of monoesters, ethers, medium chain triglycerides and branched and linear hydrocarbons which are liquid at room temperature.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102017212625.6 | 2017-07-24 | ||
| DE102017212625.6A DE102017212625A1 (en) | 2017-07-24 | 2017-07-24 | Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyldimethicone as an emulsifier, which have an aromatic content |
| PCT/EP2018/063647 WO2019020241A1 (en) | 2017-07-24 | 2018-05-24 | Water-in-oil emulsions which are based on cetyl diglyceryl tris(trimethylsiloxy)silyl ethyl dimethicones as emulsifier and contain aromates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110944619A true CN110944619A (en) | 2020-03-31 |
Family
ID=62530192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201880047512.XA Withdrawn CN110944619A (en) | 2017-07-24 | 2018-05-24 | Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane as emulsifier containing fragrance material |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP3658104A1 (en) |
| CN (1) | CN110944619A (en) |
| DE (1) | DE102017212625A1 (en) |
| WO (1) | WO2019020241A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020227908A1 (en) * | 2019-05-14 | 2020-11-19 | Beiersdorf Daily Chemical (Wuhan) Co. Ltd. | Quick breaking w/o-emulsion free from cyclomethicones |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104125973A (en) * | 2011-12-27 | 2014-10-29 | 道康宁东丽株式会社 | Co-modified organopolysiloxane, emulsifier for water-in-oil emulsion, external use preparation and cosmetic composition using same |
| WO2017037716A2 (en) * | 2015-09-03 | 2017-03-09 | Tagra Biotechnologies Ltd. | Microcapsules encapsulating a reflective agent |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10207270A1 (en) * | 2002-02-21 | 2003-09-11 | Beiersdorf Ag | Water-in-oil emulsion with surfactants and high water content |
| JP6313540B2 (en) * | 2011-12-27 | 2018-04-18 | 東レ・ダウコーニング株式会社 | Diglycerin derivative-modified silicone, emulsifier for water-in-oil emulsion containing the same, external preparation and cosmetic |
| DE102016201763A1 (en) * | 2016-02-05 | 2017-08-10 | Beiersdorf Ag | Water-in-oil emulsions based on cetyl diglyceryl tris (trimethyl-siloxy) -silylethyldimethicone as emulsifier, which are largely free of silicone oils |
-
2017
- 2017-07-24 DE DE102017212625.6A patent/DE102017212625A1/en not_active Withdrawn
-
2018
- 2018-05-24 EP EP18729357.6A patent/EP3658104A1/en not_active Withdrawn
- 2018-05-24 CN CN201880047512.XA patent/CN110944619A/en not_active Withdrawn
- 2018-05-24 WO PCT/EP2018/063647 patent/WO2019020241A1/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104125973A (en) * | 2011-12-27 | 2014-10-29 | 道康宁东丽株式会社 | Co-modified organopolysiloxane, emulsifier for water-in-oil emulsion, external use preparation and cosmetic composition using same |
| WO2017037716A2 (en) * | 2015-09-03 | 2017-03-09 | Tagra Biotechnologies Ltd. | Microcapsules encapsulating a reflective agent |
Non-Patent Citations (1)
| Title |
|---|
| CINDY DELVALLÉ ET AL: "New Formulation Possibilities with a Water-in-oil Silicone Emulsifier Suitable for PEG-free Systems", 《HTTP//WWW.DOWCORNING.COM/CONTENT/PUBLISHEDLIT/27-1463-WATER-IN-OIL-SILICONE-EMULSIFIER.PDF》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019020241A1 (en) | 2019-01-31 |
| EP3658104A1 (en) | 2020-06-03 |
| DE102017212625A1 (en) | 2019-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6346256B1 (en) | Stable O/W/O emulsion and its use as a cosmetic and/or dermatological composition | |
| US6667044B1 (en) | Cosmetic or dermatological gels based on microemulsions | |
| US20090311208A1 (en) | Oil In Silicone Emulsions and Compositions Containing Same | |
| US20070134189A1 (en) | Anti-wrinkle cosmetic | |
| EP0330369A1 (en) | Skin conditioning composition | |
| JP2011507867A (en) | Composition and method for skin treatment using an extract of the genus Trametes | |
| JP6392419B1 (en) | W / O emulsion | |
| BG107876A (en) | Vesicle forming skin oil containing w/o-emulsifiers with a hydrophilic-lipophilic balance of 2-6, methods for the production and use thereof | |
| CN110225743A (en) | Microemulsion composition and application method comprising polygonin | |
| KR101338518B1 (en) | Cosmetic composition for moisturizing W/O emulsion | |
| JPH07242824A (en) | Composition with gel-like appearance | |
| BG107875A (en) | Skin oils consisting of oil-soluble constituents | |
| JP2000026233A (en) | Preparation of w/o type emulsion containing increased water content by containing additionally one or more kinds of alkylmethicone copolyol and/or alkyldimethicone copolyol | |
| US8012460B2 (en) | Gel emulsions in the form of O/W emulsions having a hydrocolloid content | |
| ES2258844T3 (en) | PREPARED FLUID EMULSION W / O TYPE WITH GREATER WATER CONTENT. | |
| KR20160065658A (en) | Emulsifier-Free Washable Cleansing Cosmetic Composition | |
| CN110944619A (en) | Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyl polydimethylsiloxane as emulsifier containing fragrance material | |
| EP3411007B1 (en) | Water-in-oil emulsions based on cetyl diglyceryl tris (trimethylsiloxy) silylethyldimethicone as an emulgator, largely free of silicone oils | |
| US5567419A (en) | Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin | |
| CN111132650A (en) | Cosmetic or dermatological water-in-oil emulsions | |
| EP0375082A2 (en) | Cosmetic composition | |
| KR100245796B1 (en) | A water-in-oil type cosmetic composition having low viscosity | |
| WO2003053396A1 (en) | Transparent antiperspirant gel | |
| WO2021035386A1 (en) | Sunscreen composition without cyclomethicones | |
| WO2016087166A1 (en) | Cosmetic and dermatological preparations in the form of water-in-silicone oil emulsions, containing bis-(glyceryl/lauryl) glyceryl/lauryl dimethicone and dehydroacetic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200331 |